Skip to main content

Efbemalenograstim alfa Disease Interactions

There is 1 disease interaction with efbemalenograstim alfa.

Moderate

Efbemalenograstim alfa-vuxw (applies to efbemalenograstim alfa) sickle cell disorders

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Sickle Cell Anemia

Efbemalenograstim alfa-vuxw may cause severe and potentially fatal sickle cell crisis in patients with sickle cell disorders. If sickle cell crisis occurs, discontinue Efbemalenograstim alfa-vuxw.

References

  1. (2023) "Product Information. Ryzneuta (efbemalenograstim alfa)." Evive Biotech

Efbemalenograstim alfa drug interactions

There are 172 drug interactions with efbemalenograstim alfa.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer